Gemtuzumab-Ozogamicin Containing Regimens As

Gemtuzumab-Ozogamicin Containing Regimens As
Induction Therapy Give the Highest Complete Remission
Rate and the Longest Overall Survival Compared with
Other Induction Regimens in Patients with Newly
Diagnosed Acute Myeloid Leukemia
by Cristina Papayannidis, Anna Candoni, Michele Malagola, Giovanni Marconi,
Marco Manfrini, Giorgia Simonetti, Elisa Zuffa, Maria Chiara Abbenante, Sarah
Parisi, Stefania Paolini, Chiara Sartor, Eugenia Franchini, Emanuela Ottaviani,
Claudia Venturi, Maria Chiara Fontana, Antonella Padella, Viviana Guadagnuolo,
Maria Teresa Bochicchio, Anna Ferrari, Simona Soverini, Nicoletta Testoni, Carmen
Baldazzi, Renato Fanin, Domenico Russo, Michele Cavo, and Giovanni Martinelli
Blood
Volume 126(23):2513-2513
December 3, 2015
©2015 by American Society of Hematology
Cristina Papayannidis et al. Blood 2015;126:2513
©2015 by American Society of Hematology
Cristina Papayannidis et al. Blood 2015;126:2513
©2015 by American Society of Hematology
Cristina Papayannidis et al. Blood 2015;126:2513
©2015 by American Society of Hematology